first alumni evening faculty of health & social care professor gordon c wishart visiting...

11
First Alumni Evening Faculty of Health & Social Care Professor Gordon C Wishart Visiting Professor of Cancer Surgery Anglia Ruskin University Cambridge Breast Unit

Upload: geoffrey-goodwin

Post on 28-Dec-2015

216 views

Category:

Documents


0 download

TRANSCRIPT

First Alumni EveningFaculty of Health & Social

CareProfessor Gordon C WishartVisiting Professor of Cancer

SurgeryAnglia Ruskin University

Cambridge Breast Unit

Job Description

• Consultant Breast & Endocrine Surgeon• Director of Breast Services at Cambridge

Breast Unit, Addenbrooke’s Hospital.• Associate Lecturer at Cambridge University• Visiting Professor of Cancer Surgery, Anglia

Ruskin University

TrainingMB ChB (Edinburgh) July 1983

FRCS I (Glasgow) Jan 1986FRCS II (Glasgow) May 1987

MD (Edinburgh) June 1992

FRCS III (Intercollegiate) Jan1995

FRCS (Eng.) June 2001MA (Cantab.) July 2006

Cambridge Breast UnitMultidisciplinary Team

10 year all-cause survival probability 80.3% (77.1%, 83.3%)at mean age at diagnosis of 59.1 years and mean NPI of 4.22

10 year all-cause survival probability at mean age of diagnosis 59.1 yearsEPG 89.4% (87.6%, 91.2%)GPG 89.4% (87.6%, 91.2%)MPG1 87.0% (84.8%, 89.2%)MPG2 69.7% (65.2%, 74.2%)PPG 59.1% (53.5%, 64.7%)VPG 33.5% (26.9%, 40.0%)

Cambridge Breast Cancer Research Unit• £2 million raised from charitable

donors• Opened August 2009• Clinical research• Supports translational research

programme• Consulting rooms, imaging rooms,

laboratory, meeting rooms.

Clinical studies• Diagnostics: Infrared imaging, BT blood

test, elastography, tomosynthesis, axillary assessment of axilla

• Neoadjuvant chemo: NeoTanGo, Artemis

• Neoadjuvant endocrine: MONET, Artist• RT: IMPORT Low, mammosite• Targeted therapy: persephone

Prognostic and predictive breast cancer biomarkers

Research programmes

• Genetic epidemiology of predisposition and survival• Molecular classification, prognostic and predictive markers• Molecular pathology• Adult breast stem cell programme• Systemic and radiation therapy clinical trials• Cancer imaging for improved diagnosis and response to therapy

monitoring• Therapy monitoring with CTCs• Novel therapeutics (drug development)

ARU Research Opportunities

• Use HRRL for tissue processing and storage for patients in neoadjuvant therapy studies

• Aid recruitment to clinical trials in Essex• Research nurse training/appointment• BORIS• Access to research meetings, research away days

in Cambridge• Joint projects